Table 1 Clinical characteristics between V. vulnificus and non-Vibrio groups
Variables | V. vulnificus group | Non-Vibrio group | P value |
|---|---|---|---|
N (%) | N (%) | ||
Age (years, mean ± SD) | 69.1 ± 12.8 | 69.4 ± 12.5 | 0.82 |
Sex (male) | 29 (64.4%) | 58 (64.4%) | 0.99 |
Systolic blood pressure < 90 mmHg | 10 (22.2%) | 7 (7.7%) | 0.02* |
Heart rate ≧ 100/min | 24 (53.3%) | 44 (48.9%) | 0.59 |
Body temperature > 38 °C | 11 (24.4%) | 23 (25.6%) | 0.38 |
Malignancy | 3(6.7%) | 5 (5.6%) | 0.63 |
Heart disease | 7 (15.6%) | 12 (13.3%) | 0.57 |
Liver disease | 19 (42.2%) | 28 (31.1%) | < 0.03* |
Kidney disease | 13 (28.9%) | 23 (25.6%) | 0.72 |
Peripheral vascular disease | 4 (8.9%) | 7 (7.8%) | 0.41 |
Diabetes mellitus | 12 (26.7%) | 26 (28.9%) | 0.28 |
Presence of bacteremia | 29 (64.4%) | 19 (21.1%) | < 0.01* |
Seawater or seafood contact | 40 (88.9%) | 11 (12.2%) | < 0.01* |
CRP (mg/L) (mean) | 70.1 ± 78.9 | 98.6 ± 95.1 | 0.08 |
WBC (cells/mm3) (mean) | 14,870 ± 10,960 | 15,870 ± 9150 | 0.46 |
Hemoglobin (g/dL) (mean) | 12.5 ± 2.12 | 12.1 ± 1.68 | 0.29 |
Blood glucose (mg/dL) (mean) | 168 ± 74 | 196 ± 108 | 0.54 |
Sodium (mmol/L) (mean) | 135 ± 2.5 | 136 ± 2.2 | 0.18 |
Lactate (mg/dL) (mean) | 16.3 ± 7.8 | 12.8 ± 10.5 | 0.03* |
Creatinine (mg/dL) (mean) | 1.58 ± 1.15 | 1.32 ± 0.76 | 0.84 |